In our study, we demonstrated that upregulation of GBP2 expression suppresses metastasis in breast cancer cells by inhibiting Drp-1-dependent mitochondrial fission, providing further understanding of the role and mechanism of GBP2 in breast cancer. This evidence concerns the gene GBP2 and breast carcinoma.